25 XP   0   0   10

Bright Minds Biosciences Inc
Buy, Hold or Sell?

Let's analyse Bright Minds Biosciences Inc together

PenkeI guess you are interested in Bright Minds Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bright Minds Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bright Minds Biosciences Inc

I send you an email if I find something interesting about Bright Minds Biosciences Inc.

Quick analysis of Bright Minds Biosciences Inc (30 sec.)










What can you expect buying and holding a share of Bright Minds Biosciences Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.98
Expected worth in 1 year
$0.18
How sure are you?
35.7%

+ What do you gain per year?

Total Gains per Share
$-0.80
Return On Investment
-71.7%

For what price can you sell your share?

Current Price per Share
$1.12
Expected price per share
$1.09 - $1.84
How sure are you?
50%

1. Valuation of Bright Minds Biosciences Inc (5 min.)




Live pricePrice per Share (EOD)

$1.12

Intrinsic Value Per Share

$-13.08 - $-15.09

Total Value Per Share

$-12.10 - $-14.11

2. Growth of Bright Minds Biosciences Inc (5 min.)




Is Bright Minds Biosciences Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$4.3m$7.3m-$2m-38.9%

How much money is Bright Minds Biosciences Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.2m-$2.2m$1m85.2%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Bright Minds Biosciences Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#769 / 1016

Most Revenue
#1002 / 1016

Most Profit
#252 / 1016

Most Efficient
#449 / 1016

What can you expect buying and holding a share of Bright Minds Biosciences Inc? (5 min.)

Welcome investor! Bright Minds Biosciences Inc's management wants to use your money to grow the business. In return you get a share of Bright Minds Biosciences Inc.

What can you expect buying and holding a share of Bright Minds Biosciences Inc?

First you should know what it really means to hold a share of Bright Minds Biosciences Inc. And how you can make/lose money.

Speculation

The Price per Share of Bright Minds Biosciences Inc is $1.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bright Minds Biosciences Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bright Minds Biosciences Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.98. Based on the TTM, the Book Value Change Per Share is $-0.20 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bright Minds Biosciences Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.27-24.5%-0.28-24.7%-0.51-45.2%-0.39-34.4%-0.39-34.4%
Usd Book Value Change Per Share-0.09-8.2%-0.20-17.9%-0.16-14.4%0.076.3%0.076.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.09-8.2%-0.20-17.9%-0.16-14.4%0.076.3%0.076.3%
Usd Price Per Share1.43-1.01-1.07-2.04-2.04-
Price to Earnings Ratio-1.30--0.96--0.53--1.28--1.28-
Price-to-Total Gains Ratio-15.54--7.12-2.49--3.94--3.94-
Price to Book Ratio1.46-0.93-0.65-0.89-0.89-
Price-to-Total Gains Ratio-15.54--7.12-2.49--3.94--3.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.12
Number of shares892
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.200.07
Usd Total Gains Per Share-0.200.07
Gains per Quarter (892 shares)-179.0662.55
Gains per Year (892 shares)-716.23250.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-716-7260250240
20-1432-14420500490
30-2149-21580751740
40-2865-287401001990
50-3581-3590012511240
60-4297-4306015011490
70-5014-5022017511740
80-5730-5738020021990
90-6446-6454022522240
100-7162-7170025022490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.014.00.00.0%0.014.00.00.0%0.014.00.00.0%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%5.09.00.035.7%5.09.00.035.7%5.09.00.035.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.014.00.0%0.00.014.00.0%0.00.014.00.0%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%5.09.00.035.7%5.09.00.035.7%5.09.00.035.7%

Fundamentals of Bright Minds Biosciences Inc

About Bright Minds Biosciences Inc

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also developing BMB-202 for the treatment of depression, anxiety, and PTSD; and BMB-201 for the treatment of anxiety. It has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. Bright Minds Biosciences Inc. was founded in 2017 and is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2024-04-09 18:03:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Bright Minds Biosciences Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bright Minds Biosciences Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bright Minds Biosciences Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bright Minds Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--199.6%+199.6%
TTM--213.0%+213.0%
YOY--279.3%+279.3%
5Y--438.4%+438.4%
10Y--605.5%+605.5%
1.1.2. Return on Assets

Shows how efficient Bright Minds Biosciences Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bright Minds Biosciences Inc to the Biotechnology industry mean.
  • -24.5% Return on Assets means that Bright Minds Biosciences Inc generated $-0.24 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bright Minds Biosciences Inc:

  • The MRQ is -24.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -21.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.5%TTM-21.3%-3.1%
TTM-21.3%YOY-28.6%+7.3%
TTM-21.3%5Y-24.8%+3.5%
5Y-24.8%10Y-24.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.5%-13.5%-11.0%
TTM-21.3%-12.9%-8.4%
YOY-28.6%-11.8%-16.8%
5Y-24.8%-14.1%-10.7%
10Y-24.8%-16.0%-8.8%
1.1.3. Return on Equity

Shows how efficient Bright Minds Biosciences Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bright Minds Biosciences Inc to the Biotechnology industry mean.
  • -27.9% Return on Equity means Bright Minds Biosciences Inc generated $-0.28 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bright Minds Biosciences Inc:

  • The MRQ is -27.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -23.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.9%TTM-23.5%-4.5%
TTM-23.5%YOY-31.0%+7.6%
TTM-23.5%5Y-27.1%+3.6%
5Y-27.1%10Y-27.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.9%-16.9%-11.0%
TTM-23.5%-16.1%-7.4%
YOY-31.0%-15.1%-15.9%
5Y-27.1%-19.9%-7.2%
10Y-27.1%-20.9%-6.2%

1.2. Operating Efficiency of Bright Minds Biosciences Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bright Minds Biosciences Inc is operating .

  • Measures how much profit Bright Minds Biosciences Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bright Minds Biosciences Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bright Minds Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--295.1%+295.1%
TTM--225.8%+225.8%
YOY--288.4%+288.4%
5Y--477.4%+477.4%
10Y--625.6%+625.6%
1.2.2. Operating Ratio

Measures how efficient Bright Minds Biosciences Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bright Minds Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.090-3.090
TTM-3.264-3.264
YOY-3.783-3.783
5Y-5.679-5.679
10Y-7.894-7.894

1.3. Liquidity of Bright Minds Biosciences Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bright Minds Biosciences Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.01 means the company has $8.01 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bright Minds Biosciences Inc:

  • The MRQ is 8.006. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.428. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.006TTM13.428-5.421
TTM13.428YOY16.090-2.662
TTM13.4285Y24.380-10.952
5Y24.38010Y24.3800.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0063.914+4.092
TTM13.4284.220+9.208
YOY16.0905.388+10.702
5Y24.3806.045+18.335
10Y24.3806.406+17.974
1.3.2. Quick Ratio

Measures if Bright Minds Biosciences Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bright Minds Biosciences Inc to the Biotechnology industry mean.
  • A Quick Ratio of 8.07 means the company can pay off $8.07 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bright Minds Biosciences Inc:

  • The MRQ is 8.070. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 13.454. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.070TTM13.454-5.384
TTM13.454YOY16.025-2.572
TTM13.4545Y24.132-10.679
5Y24.13210Y24.1320.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0703.572+4.498
TTM13.4543.998+9.456
YOY16.0255.390+10.635
5Y24.1325.969+18.163
10Y24.1326.287+17.845

1.4. Solvency of Bright Minds Biosciences Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bright Minds Biosciences Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bright Minds Biosciences Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.12 means that Bright Minds Biosciences Inc assets are financed with 12.4% credit (debt) and the remaining percentage (100% - 12.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bright Minds Biosciences Inc:

  • The MRQ is 0.124. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.089. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.124TTM0.089+0.035
TTM0.089YOY0.077+0.012
TTM0.0895Y0.069+0.020
5Y0.06910Y0.0690.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1240.336-0.212
TTM0.0890.334-0.245
YOY0.0770.269-0.192
5Y0.0690.366-0.297
10Y0.0690.390-0.321
1.4.2. Debt to Equity Ratio

Measures if Bright Minds Biosciences Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bright Minds Biosciences Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 14.2% means that company has $0.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bright Minds Biosciences Inc:

  • The MRQ is 0.142. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.099. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.142TTM0.099+0.043
TTM0.099YOY0.085+0.014
TTM0.0995Y0.077+0.022
5Y0.07710Y0.0770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1420.382-0.240
TTM0.0990.396-0.297
YOY0.0850.335-0.250
5Y0.0770.434-0.357
10Y0.0770.465-0.388

2. Market Valuation of Bright Minds Biosciences Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bright Minds Biosciences Inc generates.

  • Above 15 is considered overpriced but always compare Bright Minds Biosciences Inc to the Biotechnology industry mean.
  • A PE ratio of -1.30 means the investor is paying $-1.30 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bright Minds Biosciences Inc:

  • The EOD is -1.022. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.304. Based on the earnings, the company is expensive. -2
  • The TTM is -0.957. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.022MRQ-1.304+0.283
MRQ-1.304TTM-0.957-0.347
TTM-0.957YOY-0.527-0.431
TTM-0.9575Y-1.283+0.325
5Y-1.28310Y-1.2830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.022-2.259+1.237
MRQ-1.304-2.569+1.265
TTM-0.957-2.664+1.707
YOY-0.527-4.120+3.593
5Y-1.283-6.258+4.975
10Y-1.283-6.171+4.888
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bright Minds Biosciences Inc:

  • The EOD is -2.093. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.672. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.426. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.093MRQ-2.672+0.579
MRQ-2.672TTM-1.426-1.247
TTM-1.426YOY-0.596-0.830
TTM-1.4265Y-1.582+0.156
5Y-1.58210Y-1.5820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.093-2.924+0.831
MRQ-2.672-3.246+0.574
TTM-1.426-3.488+2.062
YOY-0.596-5.620+5.024
5Y-1.582-8.315+6.733
10Y-1.582-8.826+7.244
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bright Minds Biosciences Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.46 means the investor is paying $1.46 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bright Minds Biosciences Inc:

  • The EOD is 1.141. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.457. Based on the equity, the company is underpriced. +1
  • The TTM is 0.926. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.141MRQ1.457-0.316
MRQ1.457TTM0.926+0.531
TTM0.926YOY0.645+0.280
TTM0.9265Y0.889+0.037
5Y0.88910Y0.8890.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.1411.851-0.710
MRQ1.4572.090-0.633
TTM0.9262.095-1.169
YOY0.6452.844-2.199
5Y0.8893.466-2.577
10Y0.8893.815-2.926
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bright Minds Biosciences Inc.

3.1. Institutions holding Bright Minds Biosciences Inc

Institutions are holding 5.15% of the shares of Bright Minds Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31AdvisorShares Investments, LLC4.21440.06391881192018912.0223
2023-12-31HRT FINANCIAL LLC0.37740.000216845347525.991
2023-12-31Renaissance Technologies Corp0.2687011996119960
2023-12-31Virtu Financial LLC0.2330.001210399-2705-20.6426
2023-12-31UBS Group AG0.013906226220
2023-12-31Royal Bank of Canada0.00620278182189.5833
2023-12-31Aspire Private Capital, LLC0.0022010000
2023-12-31BlackRock Inc001-1-50
Total 5.11580.0653228360+33758+14.8%

3.2. Funds holding Bright Minds Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-28AdvisorShares Psychedelics ETF3.94372.860317603800
Total 3.94372.860317603800.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Bright Minds Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.092-0.201+118%-0.161+75%0.070-231%0.070-231%
Book Value Per Share--0.9821.192-18%1.656-41%1.794-45%1.794-45%
Current Ratio--8.00613.428-40%16.090-50%24.380-67%24.380-67%
Debt To Asset Ratio--0.1240.089+39%0.077+61%0.069+79%0.069+79%
Debt To Equity Ratio--0.1420.099+43%0.085+67%0.077+83%0.077+83%
Dividend Per Share----0%-0%-0%-0%
Eps---0.274-0.277+1%-0.506+85%-0.385+41%-0.385+41%
Free Cash Flow Per Share---0.134-0.211+58%-0.460+244%-0.337+152%-0.337+152%
Free Cash Flow To Equity Per Share--0.009-0.178+2052%-0.161+1873%0.073-88%0.073-88%
Gross Profit Margin--1.0221.018+0%1.028-1%1.042-2%1.042-2%
Intrinsic Value_10Y_max---15.091--------
Intrinsic Value_10Y_min---13.082--------
Intrinsic Value_1Y_max---1.527--------
Intrinsic Value_1Y_min---1.499--------
Intrinsic Value_3Y_max---4.576--------
Intrinsic Value_3Y_min---4.369--------
Intrinsic Value_5Y_max---7.612--------
Intrinsic Value_5Y_min---7.066--------
Market Cap4999388.800-28%6383148.2004508377.400+42%4784013.345+33%9115913.596-30%9115913.596-30%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1.141-28%1.4570.926+57%0.645+126%0.889+64%0.889+64%
Pe Ratio-1.022+22%-1.304-0.957-27%-0.527-60%-1.283-2%-1.283-2%
Price Per Share1.120-28%1.4301.010+42%1.072+33%2.042-30%2.042-30%
Price To Free Cash Flow Ratio-2.093+22%-2.672-1.426-47%-0.596-78%-1.582-41%-1.582-41%
Price To Total Gains Ratio-12.174+22%-15.544-7.118-54%2.486-725%-3.942-75%-3.942-75%
Quick Ratio--8.07013.454-40%16.025-50%24.132-67%24.132-67%
Return On Assets---0.245-0.213-13%-0.286+17%-0.248+2%-0.248+2%
Return On Equity---0.279-0.235-16%-0.310+11%-0.271-3%-0.271-3%
Total Gains Per Share---0.092-0.201+118%-0.161+75%0.070-231%0.070-231%
Usd Book Value--4382297.1075321481.641-18%7391787.017-41%8009811.120-45%8009811.120-45%
Usd Book Value Change Per Share---0.092-0.201+118%-0.161+75%0.070-231%0.070-231%
Usd Book Value Per Share--0.9821.192-18%1.656-41%1.794-45%1.794-45%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.274-0.277+1%-0.506+85%-0.385+41%-0.385+41%
Usd Free Cash Flow---597163.997-941174.688+58%-2052046.767+244%-1502786.697+152%-1502786.697+152%
Usd Free Cash Flow Per Share---0.134-0.211+58%-0.460+244%-0.337+152%-0.337+152%
Usd Free Cash Flow To Equity Per Share--0.009-0.178+2052%-0.161+1873%0.073-88%0.073-88%
Usd Market Cap4999388.800-28%6383148.2004508377.400+42%4784013.345+33%9115913.596-30%9115913.596-30%
Usd Price Per Share1.120-28%1.4301.010+42%1.072+33%2.042-30%2.042-30%
Usd Profit---1223451.549-1236180.801+1%-2289917.706+87%-1733741.634+42%-1733741.634+42%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.092-0.201+118%-0.161+75%0.070-231%0.070-231%
 EOD+3 -5MRQTTM+18 -12YOY+19 -115Y+10 -2010Y+10 -20

4.2. Fundamental Score

Let's check the fundamental score of Bright Minds Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.022
Price to Book Ratio (EOD)Between0-11.141
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.070
Current Ratio (MRQ)Greater than18.006
Debt to Asset Ratio (MRQ)Less than10.124
Debt to Equity Ratio (MRQ)Less than10.142
Return on Equity (MRQ)Greater than0.15-0.279
Return on Assets (MRQ)Greater than0.05-0.245
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Bright Minds Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.314
Ma 20Greater thanMa 501.225
Ma 50Greater thanMa 1001.498
Ma 100Greater thanMa 2001.605
OpenGreater thanClose1.140
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets6,887
Total Liabilities854
Total Stockholder Equity6,033
 As reported
Total Liabilities 854
Total Stockholder Equity+ 6,033
Total Assets = 6,887

Assets

Total Assets6,887
Total Current Assets6,839
Long-term Assets48
Total Current Assets
Cash And Cash Equivalents 6,675
Short-term Investments 86
Net Receivables 45
Other Current Assets 32
Total Current Assets  (as reported)6,839
Total Current Assets  (calculated)6,839
+/-0
Long-term Assets
Property Plant Equipment 48
Long-term Assets Other 0
Long-term Assets  (as reported)48
Long-term Assets  (calculated)48
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities854
Long-term Liabilities0
Total Stockholder Equity6,033
Total Current Liabilities
Short-term Debt 55
Accounts payable 800
Other Current Liabilities 800
Total Current Liabilities  (as reported)854
Total Current Liabilities  (calculated)1,654
+/- 800
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock35,047
Retained Earnings -33,231
Accumulated Other Comprehensive Income 4,217
Total Stockholder Equity (as reported)6,033
Total Stockholder Equity (calculated)6,033
+/-0
Other
Capital Stock35,047
Cash and Short Term Investments 6,762
Common Stock Shares Outstanding 3,843
Current Deferred Revenue-800
Liabilities and Stockholders Equity 6,887
Net Debt -6,621
Net Invested Capital 6,033
Net Working Capital 5,985
Property Plant and Equipment Gross 48
Short Long Term Debt Total 55



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
> Total Assets 
0
0
0
880
2,184
25,742
22,215
20,040
15,413
11,763
8,820
12,087
11,550
9,987
8,461
6,879
6,887
6,8876,8798,4619,98711,55012,0878,82011,76315,41320,04022,21525,7422,184880000
   > Total Current Assets 
0
0
0
878
2,182
25,740
22,213
20,038
15,411
11,761
8,818
11,948
11,429
9,884
8,376
6,813
6,839
6,8396,8138,3769,88411,42911,9488,81811,76115,41120,03822,21325,7402,182878000
       Cash And Cash Equivalents 
0
0
0
800
2,065
25,450
22,007
19,760
15,119
11,468
8,641
11,628
11,212
9,672
8,131
6,748
6,675
6,6756,7488,1319,67211,21211,6288,64111,46815,11919,76022,00725,4502,065800000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
86
86
86
86
86
86
86
868686868686860000000000
       Net Receivables 
0
0
0
0
1
37
78
110
150
208
96
156
59
33
104
37
45
4537104335915696208150110783710000
       Other Current Assets 
0
0
0
0
117
253
128
0
0
0
80
164
158
179
142
28
32
3228142179158164800001282531170000
   > Long-term Assets 
0
0
0
2
2
2
2
2
2
2
2
139
121
103
85
66
48
48668510312113922222222000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
139
121
103
85
66
48
48668510312113900000000000
       Intangible Assets 
0
0
0
0
0
0
0
2,000,000
0
0
2
0
0
0
0
0
0
0000002002,000,0000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000
> Total Liabilities 
0
0
0
151
95
409
323
639
490
1,004
385
1,544
583
1,041
735
281
854
8542817351,0415831,5443851,00449063932340995151000
   > Total Current Liabilities 
0
0
0
151
95
409
323
639
490
1,004
385
1,472
528
1,006
721
281
854
8542817211,0065281,4723851,00449063932340995151000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
68
70
74
77
74
55
55747774706800000000000
       Accounts payable 
0
0
0
138
95
409
323
597
483
995
385
1,246
322
248
643
182
800
8001826432483221,24638599548359732340995138000
       Other Current Liabilities 
0
0
0
13
23
0
0
42
7
9
0
158
136
684
643
25
800
8002564368413615809742002313000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
995
385
72
55
35
14
0
0
0014355572385995000000000
> Total Stockholder Equity
0
0
0
729
2,089
25,332
21,892
19,402
14,923
10,760
8,434
10,543
10,967
8,946
7,726
6,598
6,033
6,0336,5987,7268,94610,96710,5438,43410,76014,92319,40221,89225,3322,089729000
   Common Stock
0
0
0
981
3,003
27,240
27,049
27,080
27,178
27,167
27,189
32,238
33,682
33,914
33,914
33,914
35,047
35,04733,91433,91433,91433,68232,23827,18927,16727,17827,08027,04927,2403,003981000
   Retained Earnings Total Equity00000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
161
398
926
1,219
1,565
1,846
2,148
2,447
2,479
2,964
2,761
2,999
3,399
4,217
4,2173,3992,9992,7612,9642,4792,4472,1481,8461,5651,219926398161000
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
0
0
146
279
-24
-34
19,401,795,000
-34
2,148
12
10,542,512,000
832
832
832
832
0
083283283283210,542,512,000122,148-3419,401,795,000-34-24279146000



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-72
Gross Profit-72-72
 
Operating Income (+$)
Gross Profit-72
Operating Expense-7,386
Operating Income-7,401-7,459
 
Operating Expense (+$)
Research Development5,000
Selling General Administrative2,080
Selling And Marketing Expenses119
Operating Expense7,3867,200
 
Net Interest Income (+$)
Interest Income0
Interest Expense-20
Other Finance Cost-20
Net Interest Income0
 
Pretax Income (+$)
Operating Income-7,401
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,372-7,415
EBIT - interestExpense = -7,420
-7,386
-7,352
Interest Expense20
Earnings Before Interest and Taxes (EBIT)-7,401-7,352
Earnings Before Interest and Taxes (EBITDA)-7,328
 
After tax Income (+$)
Income Before Tax-7,372
Tax Provision-0
Net Income From Continuing Ops-7,372-7,372
Net Income-7,372
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,386
Total Other Income/Expenses Net140
 

Technical Analysis of Bright Minds Biosciences Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bright Minds Biosciences Inc. The general trend of Bright Minds Biosciences Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bright Minds Biosciences Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bright Minds Biosciences Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.45 < 1.8 < 1.84.

The bearish price targets are: 1.11 > 1.09.

Tweet this
Bright Minds Biosciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bright Minds Biosciences Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bright Minds Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bright Minds Biosciences Inc. The current macd is -0.0853539.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bright Minds Biosciences Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bright Minds Biosciences Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bright Minds Biosciences Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Bright Minds Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartBright Minds Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bright Minds Biosciences Inc. The current adx is 21.10.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bright Minds Biosciences Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Bright Minds Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bright Minds Biosciences Inc. The current sar is 1.38780475.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Bright Minds Biosciences Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bright Minds Biosciences Inc. The current rsi is 37.31. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Bright Minds Biosciences Inc Daily Relative Strength Index (RSI) ChartBright Minds Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bright Minds Biosciences Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bright Minds Biosciences Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Bright Minds Biosciences Inc Daily Stochastic Oscillator ChartBright Minds Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bright Minds Biosciences Inc. The current cci is -117.42856849.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Bright Minds Biosciences Inc Daily Commodity Channel Index (CCI) ChartBright Minds Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bright Minds Biosciences Inc. The current cmo is -27.12308926.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Bright Minds Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartBright Minds Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bright Minds Biosciences Inc. The current willr is -97.05882353.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Bright Minds Biosciences Inc Daily Williams %R ChartBright Minds Biosciences Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bright Minds Biosciences Inc. The current atr is 0.11732925.

Bright Minds Biosciences Inc Daily Average True Range (ATR) ChartBright Minds Biosciences Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bright Minds Biosciences Inc. The current obv is 128,726,517.

Bright Minds Biosciences Inc Daily On-Balance Volume (OBV) ChartBright Minds Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bright Minds Biosciences Inc. The current mfi is 45.71.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Bright Minds Biosciences Inc Daily Money Flow Index (MFI) ChartBright Minds Biosciences Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bright Minds Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Bright Minds Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bright Minds Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.314
Ma 20Greater thanMa 501.225
Ma 50Greater thanMa 1001.498
Ma 100Greater thanMa 2001.605
OpenGreater thanClose1.140
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bright Minds Biosciences Inc with someone you think should read this too:
  • Are you bullish or bearish on Bright Minds Biosciences Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bright Minds Biosciences Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bright Minds Biosciences Inc

I send you an email if I find something interesting about Bright Minds Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Bright Minds Biosciences Inc.

Receive notifications about Bright Minds Biosciences Inc in your mailbox!